Company / Operating Cash Flow per Share
Outlook Therapeutics, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.88
FY2025
5-year range
-$3.66 / -$0.62
FY2021-FY2025
Trend
-155.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-3.66 in FY2019 to $-0.62 in FY2018.
Based on SEC 10-K filings.
-2.88 in FY2025.
Improved from $-3.66 to $-2.88 over the past 6 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 155.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.88 | -155.0% |
| FY2020 | -$1.13 | +69.2% |
| FY2019 | -$3.66 | -488.6% |
| FY2018 | -$0.62 | +68.8% |
| FY2017 | -$1.99 | +31.5% |
| FY2016 | -$2.91 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026